Table 1.

Clinical features and genetic diagnosis of the patients of PKD.

Patient No.	PRRT2 mutation	Gender	AOE	AON	DD	Frequency/month	Duration (second)	Family history
1	R217EfsX	M	38	9	29	10–20	10	N
2	R217PfsX	M	28	11	17	20–30	10–15	N
3	R217PfsX	F	24	16	8	20–30	10–15	Y
4	R217PfsX	M	19	12	7	20–30	5–10	Y
5	G324EfsX	M	26	12	14	20–30	5–10	Y
6	N	M	18	13	5	5–10	< 5	N
7	N	M	25	10	15	20–30	5–10	N
8	N	M	19	16	3	20–30	< 5	N
9	N	M	18	13	5	20–30	5–10	Y
10	N	M	23	14	9	20–30	5–10	N
11	N	F	17	12	5	< 5	< 5	Y
12	N	M	27	14	13	20–30	20–30	N
13	N	M	23	10	13	20–30	5–10	Y
14	N	F	17	11	6	20–30	5–10	Y
15	N	M	26	10	16	10–20	5–10	N
16	N	F	38	20	18	10–20	5–10	N
17	N	M	27	10	17	5–10	5–10	N
18	N	M	25	13	12	20–30	20–30	N
19	N	M	25	17	8	< 5	20–30	N
PRRT2-related PKD			27.0 ± 7.0	12.0 ± 7.9	15.0 ± 8.9	/	/	60%
Non-PRRT2 PKD			23.4 ± 5.6	13.1 ± 3.0	10.4 ± 5.1	/	/	28.6%

AOE, Age of examination (year); AON, Age of onset (year); DD, disease duration (AOE-AON, year); Duration: duration of each attack; N, no; Y, yes.